IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer

RTTNews | 947 days ago
Stocktwits
IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer

(RTTNews) - Oncology company IDEAYA Biosciences, Inc. (IDYA) announced that Darrin Beaupre has joined the company as its Chief Medical Officer, effective November 21, 2022.

Beaupre's extensive career includes various clinical development and translational research roles in industry, including most recently at BioSplice Therapeutics as Chief Medical Officer and Head of Research and Development in Oncology.

Beaupre previously served as Senior Vice President, Head of Early Oncology Development and Clinical Research at Pfizer, Inc., where he led cross-disciplinary groups including clinical development, clinical pharmacology, translational oncology and clinical operations related study clinicians.

Beaupre also served at Pharmacyclics (Abbvie) as Vice President, Head of Early Development and Immunotherapy, and at Amgen as Medical Director.

He was previously an Assistant Professor at the H. Lee Moffitt Cancer Center and Research Institute, and also held various earlier appointments at the University of Miami and the M.D. Anderson Cancer Center.

Tags: IDYA
Stocktwits
read more
IDEAYA Biosciences Q4 Results Misses Estimates

IDEAYA Biosciences Q4 Results Misses Estimates

IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, announced net loss of $32.64 million or $0.52 per share, wider than $23.07 million or $0.50 per share in the prior-year quarter.
RTTNews | 498 days ago
IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101

IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101

Oncology company IDEAYA Biosciences, Inc. (IDYA) announced Monday the clearance of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for initiation of a GSK-sponsored Phase 1/2 clinical trial to evaluate GSK101 (IDE705) for the treatment of patients having tumors with BRCA or other homologous recombination (HR) mutations or homologous recombination deficiency (HRD).
RTTNews | 681 days ago
Canadian Market Down Marginally In Lackluster Trade

Canadian Market Down Marginally In Lackluster Trade

The Canadian market is down in negative territory in lackluster trade on Wednesday as investors largely refrain from making significant moves, choosing to wait for directional clues from the trade front.
RTTNews | 1h 34min ago
Swiss Market Closes Modestly Higher

Swiss Market Closes Modestly Higher

Despite struggling for direction for much of the day's trading session, the Switzerland market closed modestly higher on Wednesday as select stocks found some good support in the final hour. The mood was cautious with investors awaiting further news on the trade front, and the data on Swiss inflation and unemployment, due later in the week.
RTTNews | 2h 2min ago
European Stocks Close Broadly Higher

European Stocks Close Broadly Higher

European stocks closed higher on Wednesday as investors continued to closely watch trade negotiations between the U.S. and major countries across the globe ahead of the July 9 deadline for reciprocal tariffs.
RTTNews | 2h 19min ago
Paramount To Pay $16 Mln To Settle Lawsuit By Trump Over Interview With Kamala Harris

Paramount To Pay $16 Mln To Settle Lawsuit By Trump Over Interview With Kamala Harris

Media firm Paramount Global has agreed to pay $16 million to settle a legal dispute with U.S. President Donald Trump, over its '60 Minutes' interview with former Vice President Kamala Harris, reports said. The interview was broadcast on Paramount's affiliated CBS network last year, ahead of the 2024 Presidential election.
RTTNews | 5h 23min ago
Bay Street Likely To Open With Positive Bias

Bay Street Likely To Open With Positive Bias

Canadian shares look set to open with a positive bias on Wednesday, tracking steady European markets and higher crude oil prices. Optimism about Canada and the U.S. striking a trade deal is likely to help underpin sentiment.
RTTNews | 6h 52min ago
Tools
Economic Calendar
Market Hours
Interest Rates
Holidays Calendar
Forex Market
Forex Volatility
Forex Correlation
Forex News
forex analysis
COT Data
Liquidity
Forex Calculators
Forex Heat Map
Indicators Heatmap
Community
Community
Systems
Most Popular Systems
Strategies
Contests
Forex Charts
Forex Sentiment
Sentiment Indicator
Reviews
Brokers
Prop Trading Firms
VPS Services
Signal Providers
EA Programming Services
Affiliate Programs
PAMM Broker Services
Rebate Program Services
Trading Platforms
Expert Advisors
Crypto Exchanges
Trading Courses
Brokers
Forex Spreads
Forex Broker Quotes
Forex Broker Swaps
Forex Broker Volume
Forex Broker Promotions Press Release
Platform
Widgets
Features
API
RSS
Stock Portfolio
Affiliate Software
Advanced Charts
Support
FAQ
Help
Contact Us
Report a Bug!
About
Blog
© 2025 Myfxbook Ltd. All Rights Reserved.
HIGH RISK WARNING: Foreign exchange trading carries a high level of risk that may not be suitable for all investors. Leverage creates additional risk and loss exposure. Before you decide to trade foreign exchange, carefully consider your investment objectives, experience level, and risk tolerance. You could lose some or all of your initial investment. Do not invest money that you cannot afford to lose. Educate yourself on the risks associated with foreign exchange trading, and seek advice from an independent financial or tax advisor if you have any questions. Any data and information is provided 'as is' solely for informational purposes, and is not intended for trading purposes or advice. Past performance is not indicative of future results.